Published in Per Med on March 01, 2016
The fundamental role of epigenetic events in cancer. Nat Rev Genet (2002) 30.05
DNA methylation and breast carcinogenesis. Oncogene (2002) 3.03
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nat Genet (2015) 3.02
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer (2011) 2.28
Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation. Genome Med (2012) 1.65
A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. Cancer Res (2009) 1.65
Correlation of Smoking-Associated DNA Methylation Changes in Buccal Cells With DNA Methylation Changes in Epithelial Cancer. JAMA Oncol (2015) 1.19
Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer. J Natl Cancer Inst (2014) 1.14
Stratified cancer screening: the practicalities of implementation. Public Health Genomics (2013) 1.11
Genome-based prediction of breast cancer risk in the general population: a modeling study based on meta-analyses of genetic associations. Cancer Epidemiol Biomarkers Prev (2011) 1.09
The role of epigenetics in genetic and environmental epidemiology. Epigenomics (2015) 1.02
Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis. Genet Med (2015) 1.01
Epigenetics: principles and practice. Dig Dis (2011) 0.98
The dynamics of DNA methylation covariation patterns in carcinogenesis. PLoS Comput Biol (2014) 0.96
Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling. Cancer Epidemiol Biomarkers Prev (2012) 0.94
A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival. Genome Med (2014) 0.93
Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation. Carcinogenesis (2013) 0.92
Epigenetics makes its mark on women-specific cancers--an opportunity to redefine oncological approaches? Gynecol Oncol (2012) 0.86
Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC. Br J Cancer (2015) 0.82
Personalized screening for cancers: should we consider polygenic profiling? Per Med (2013) 0.94